Log In
Print
BCIQ
Print
Print this Print this
 

ACE-031, HGT-4510

  Manage Alerts
Collapse Summary General Information
Company Acceleron Pharma Inc.
DescriptionRecombinant fusion protein produced by joining a portion of the human ActRIIB receptor to a portion of a human antibody
Molecular Target Myostatin (GDF-8)
Mechanism of ActionActivin receptor type 2B (ACVR2B) antagonist
Latest Stage of DevelopmentPhase II
IndicationMuscular dystrophy
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today